Jason Pontin Finds LLMs Unimpressive

Jason Pontin replied on the platform that he remains in awe of proprietary biology models yet finds himself unimpressed at some deep level by the LLMs. The post, addressed to Gary Marcus and two other accounts, comes from the general partner at DCVC who cofounded Totus Medicines and chairs or serves on boards of AI biotech firms. Pontin previously served as editor in chief and CEO of MIT Technology Review. The packet records only this single reply and the account details supplied with it.